These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 18163938)

  • 1. Salvage options for biochemical recurrence after primary therapy for prostate cancer.
    Bong GW; Keane TE
    Can J Urol; 2007 Dec; 14 Suppl 1():2-9. PubMed ID: 18163938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.
    Simmons MN; Stephenson AJ; Klein EA
    Eur Urol; 2007 May; 51(5):1175-84. PubMed ID: 17240528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy.
    Stephenson AJ; Slawin KM
    Nat Clin Pract Urol; 2004 Dec; 1(2):90-6. PubMed ID: 16474521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of men with rising prostate-specific antigen levels following radical prostatectomy.
    Tzou K; Tan WW; Buskirk S
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):125-36. PubMed ID: 21166517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
    Stephenson AJ; Eastham JA
    J Clin Oncol; 2005 Nov; 23(32):8198-203. PubMed ID: 16278473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy for locally recurrent prostate cancer.
    Kirkpatrick JP; Anscher MS
    Clin Adv Hematol Oncol; 2005 Dec; 3(12):933-42. PubMed ID: 16555435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer.
    Naito S
    Jpn J Clin Oncol; 2005 Jul; 35(7):365-74. PubMed ID: 15976063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic strategy for prostate specific antigen (PSA) failure after radical prostatectomy].
    Kinoshita H; Kamoto T; Mitsumori M; Kiyokawa T; Habuchi T; Kakehi Y; Hiraoka M; Ogawa O
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):32-7. PubMed ID: 12557702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSA relapse prostate cancer: the importance of tailored therapy.
    Aranha O; Vaishampayan U
    Urol Oncol; 2004; 22(1):62-9. PubMed ID: 14969807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An algorithm for managing the failure of external beam radiotherapy in prostate cancer.
    Dudderidge T; Payne H; Emberton M
    BJU Int; 2007 Sep; 100(3):518-27. PubMed ID: 17573894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.
    Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy.
    King CR; Presti JC; Brooks JD; Gill H; Spiotto MT
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1472-7. PubMed ID: 17935902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option.
    Allen GW; Howard AR; Jarrard DF; Ritter MA
    Cancer; 2007 Oct; 110(7):1405-16. PubMed ID: 17685384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential treatment for recurrent localized prostate cancer.
    Van Der Poel HG; Moonen L; Horenblas S
    J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
    Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
    Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
    Leonardo C; Simone G; Papalia R; Franco G; Guaglianone S; Gallucci M
    Int J Urol; 2009 Jun; 16(6):584-6. PubMed ID: 19453762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen recurrence after definitive therapy.
    Freedland SJ; Moul JW
    J Urol; 2007 Jun; 177(6):1985-91. PubMed ID: 17509277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
    Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
    J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.